Kenneth Krogulski - 17 Mar 2025 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
17 Mar 2025
Transactions value $
$25,850
Form type
4
Filing time
18 Mar 2025, 17:15:06 UTC
Previous filing
04 Apr 2025
Next filing
09 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Award $5,170 +1,000 +0.36% $5.17 278,843 17 Mar 2025 Direct F1
transaction CPIX Common Stock Award $20,680 +4,000 +1.43% $5.17 282,843 17 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock award will vest 100% on March 17, 2026.